TAHIR SIDDIQUE; SADAF FARZAND; MARRYAM KHALID; RIZWAN AHMAD; KASHIF AZIZ AHMAD; MUHAMMAD MAQSOOD. Efficacy and Safety of Once-Weekly Semaglutide versus Tirzepatide in Type 2 Diabetes: A 24-Week Randomized Clinical Trial. Journal of Health, Wellness and Community Research, [S. l.], v. 3, n. 1, p. 1–8, 2025. DOI: 10.61919/qxt0b644. Disponível em: https://jhwcr.com/index.php/jhwcr/article/view/1948. Acesso em: 20 jul. 2026.